ESR1 gene amplification in breast cancer: a common phenomenon?

doi:10.1038/ng0708-806

Comparative Study

. 2008 Jul;40(7):806-7; author reply 810-2.

doi: 10.1038/ng0708-806.

ESR1 gene amplification in breast cancer: a common phenomenon?

Lindsay A Brown, Jeremy Hoog, Suet-Feung Chin, Yu Tao, Abd Alnaser Zayed, Koei Chin, Andrew E Teschendorff, John F Quackenbush, John C Marioni, Samuel Leung, Charles M Perou, Torsten O Neilsen, Matthew Ellis, Joe W Gray, Philip S Bernard, David G Huntsman, Carlos Caldas

PMID: 18583964
PMCID: PMC2846830
DOI: 10.1038/ng0708-806

Comparative Study

ESR1 gene amplification in breast cancer: a common phenomenon?

Lindsay A Brown et al. Nat Genet. 2008 Jul.

. 2008 Jul;40(7):806-7; author reply 810-2.

doi: 10.1038/ng0708-806.

Authors

PMID: 18583964
PMCID: PMC2846830
DOI: 10.1038/ng0708-806

No abstract available

PubMed Disclaimer

Comment in

Conflicting evidence on the frequency of ESR1 amplification in breast cancer.
Albertson DG. Albertson DG. Nat Genet. 2008 Jul;40(7):821-2. doi: 10.1038/ng0708-821. Nat Genet. 2008. PMID: 18583976 No abstract available.

Comment on

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.
Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, Sauter G, Simon R. Holst F, et al. Nat Genet. 2007 May;39(5):655-60. doi: 10.1038/ng2006. Epub 2007 Apr 8. Nat Genet. 2007. PMID: 17417639

Cited by

Androgen receptor as a targeted therapy for breast cancer.
Garay JP, Park BH. Garay JP, et al. Am J Cancer Res. 2012;2(4):434-45. Epub 2012 Jun 28. Am J Cancer Res. 2012. PMID: 22860233 Free PMC article.
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.
Holst F. Holst F. World J Clin Oncol. 2016 Apr 10;7(2):160-73. doi: 10.5306/wjco.v7.i2.160. World J Clin Oncol. 2016. PMID: 27081639 Free PMC article. Review.
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.
Basudan A, Priedigkeit N, Hartmaier RJ, Sokol ES, Bahreini A, Watters RJ, Boisen MM, Bhargava R, Weiss KR, Karsten MM, Denkert C, Blohmer JU, Leone JP, Hamilton RL, Brufsky AM, Elishaev E, Lucas PC, Lee AV, Oesterreich S. Basudan A, et al. Mol Cancer Res. 2019 Feb;17(2):457-468. doi: 10.1158/1541-7786.MCR-18-0946. Epub 2018 Oct 24. Mol Cancer Res. 2019. PMID: 30355675 Free PMC article.
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals.
Szostakowska M, Trębińska-Stryjewska A, Grzybowska EA, Fabisiewicz A. Szostakowska M, et al. Breast Cancer Res Treat. 2019 Feb;173(3):489-497. doi: 10.1007/s10549-018-5023-4. Epub 2018 Nov 1. Breast Cancer Res Treat. 2019. PMID: 30382472 Free PMC article. Review.
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
Pentheroudakis G, Kotoula V, Eleftheraki AG, Tsolaki E, Wirtz RM, Kalogeras KT, Batistatou A, Bobos M, Dimopoulos MA, Timotheadou E, Gogas H, Christodoulou C, Papadopoulou K, Efstratiou I, Scopa CD, Papaspyrou I, Vlachodimitropoulos D, Linardou H, Samantas E, Pectasides D, Pavlidis N, Fountzilas G. Pentheroudakis G, et al. PLoS One. 2013 Jul 29;8(7):e70634. doi: 10.1371/journal.pone.0070634. Print 2013. PLoS One. 2013. PMID: 23923010 Free PMC article.

See all "Cited by" articles

References

1. Holst F, et al. Nat. Genet. 2007;39:655–660. - PubMed
1. Brown LA, Huntsman D. J. Mol. Histol. 2007;38:151–157. - PubMed
1. Chin SF, et al. Genome Biol. 2007;8:R215. - PMC - PubMed
1. van den Ijssel P, et al. Nucleic Acids Res. 2005;33:e192. - PMC - PubMed
1. Chin K, et al. Cancer Cell. 2006;10:529–541. - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Holst F, et al. Nat. Genet. 2007;39:655–660. - PubMed

[2] Holst F, et al. Nat. Genet. 2007;39:655–660. - PubMed

[3] Brown LA, Huntsman D. J. Mol. Histol. 2007;38:151–157. - PubMed

[4] Brown LA, Huntsman D. J. Mol. Histol. 2007;38:151–157. - PubMed

[5] Chin SF, et al. Genome Biol. 2007;8:R215. - PMC - PubMed

[6] Chin SF, et al. Genome Biol. 2007;8:R215. - PMC - PubMed

[7] van den Ijssel P, et al. Nucleic Acids Res. 2005;33:e192. - PMC - PubMed

[8] van den Ijssel P, et al. Nucleic Acids Res. 2005;33:e192. - PMC - PubMed

[9] Chin K, et al. Cancer Cell. 2006;10:529–541. - PubMed

[10] Chin K, et al. Cancer Cell. 2006;10:529–541. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ESR1 gene amplification in breast cancer: a common phenomenon?

ESR1 gene amplification in breast cancer: a common phenomenon?

Authors

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous